An increased risk of cervical intra-epithelial neoplasia grade II-III among human papillomavirus positive patients with the HLA-DQA1*0102- DQB1*0602 haplotype: A population-based case-control study of Norwegian women

International Journal of Cancer

Volumn 76, Issue 1, 1998, Pages 19-24

  Helland, Åslaug ^a   Olsen, Anne O ^b   Gjøen, Kirsti ^b   Akselsen, Hanne E ^a   Sauer, Torill ^c   Magnus, Per ^b   Børresen Dale, Anne Lise ^a,d   Rønningen, Kjersti S ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN;

ADULT; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; GENETIC SUSCEPTIBILITY; HIGH RISK POPULATION; HISTOPATHOLOGY; HLA TYPING; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MARKER GENE; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; UTERINE CERVIX CANCER; VIRUS INFECTION; WART VIRUS;

ADULT; CARCINOMA IN SITU; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HAPLOTYPES; HLA-D ANTIGENS; HUMANS; NORWAY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 0031959893     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980330)76:1<19::AID-IJC4>3.0.CO;2-0     Document Type: Article

References (42)

1. ALLEN, M., KALANTARI, M., YLITALO, N., PETTERSSON, B., HAGMAR, B., SCHEIBENPFLUG, L., JOHANSSON, B., PFTTERSON, U. and GYLLENSTEN, U., HLA DQ-DR haplotype and susceptibility to cervical carcinoma: indications of increased risk for development of cervical carcinoma in individuals infected with HPV 18. Tissue Antigens, 48, 32-37 (1996).
2. APPLE, R.J., BECKER, T.M., WHEELER, C.M. and ERLICH, H.A., Comparison ot HLA DR-DQ disease associations found with cervical dysplusia and invasive cervical carcinoma. J. nat. Cancer Inst., 87, 427-436 (1995).
3. APPLE, R.J., ERLICH, H.A., KLITZ, W., MANOS, M.M., BECKER, T.M. and WHEELER, C.M., HLA DR-DQ associations with cervical carcinoma show papillomavirus type specificity. Nature (Genet.), 6, 157-162 (1994).
4. BODMER, J.G., and 16 OTHERS, Nomenclature for factors of the HLA system, 1996. Tissue Antigens, 49, 297-321 (1997).
5. BOSCH, F.X., MANOS, M.M., MUÑOZ, N., SHERMAN, M., JANSEN, A.M., PETO, J., SCHIFFMAN, M.H., MORENO, V., KURMAN, R. and SHAH K.V., INTERNATIONAL BIOLOGICAL STUDY ON CERVICAL CANCER (IBSCC) STUDY GROUP. Prevalence of human pupillomavirus in cervical cancer: a world-wide perspective. J. nat. Cancer Inst., 87, 796-802 (1995).
6. CZARNECKI, D.B., LEWIS, A., NICHOLSON, I. and TAIT, B., Multiple non-melanoma skin cancer associated with HLA DR7 in Southern Australia. Cancer, 68, 439-440 (1991).
7. DAVID, A.L.M., TAYLOR, G.M., GOKHALE, D., APLIN, J.D., SEIF, M.W. and TINDALL, V.R., HLA-DQBa*03 and cervical intraepithelial neoplasia type III. Lancet, 340, 52 (1992).
8. DAVIES, D.H. and STAUSS, H.J., The significance of human leukocyte antigen association with cervical cancer. Papillomavirus Rep., 8, 43-50 (1997).
9. DEAN, J., DEAN, A. and BURTON, J., Epi-Info, Public domain software for epidemiology and disease surveillance. WHO AIDS Series (1990).
10. GJØEN, K., OLSEN, A.O., MAGNUS, P., GRINDE, B., SAUER, T. and ØRSTAVIK, I., Prevalence of human papillomavirus in cervical scrapes, as analyzed by PCR, in a population-based sample of women with and without cervical dysplasia. Acta pathol. microbiol. imnnmol. scand., 104, 68-74 (1996).
11. GLEW, S., DUGGAN-KEEN, M., GHOSH, A.K., IVINSON, A., SINNOT, P., DAVIDSON, J., DYER, P.A. and STERN, P.L., Lack of association of HLA polymorphisms with human papillomavirus-related cervical cancer. Hum. Immunol., 37, 157-164 (1993).
12. GLEW, S.S., STERN, P.L., DAVIDSON, J.A. and DYER, P.A., HLA antigens and cervical carcinoma. Nature (Lond.), 356, 22 (1992).
13. GREGOIRE, L., LAWRENCE, W., KUKURUGA, D., EISENBREY, A. and LANCASTER, W.D., Association between HLA-DQB1 alleles and risk for cervical cancer in African American women. Int. J. Cancer, 57, 504-507 (1994).
14. HAN, R., BREITBURD, F., MARCHE, P.N. and ORTH, G., Linkage of regression and malienant conversion of rabbit viral papillomas to MHC class-U genes. Nature (Loud.), 356, 66-68 (1992).
15. HELLAND, Å, BØRRESEN, A.-L., KAERN, J., RØNNINGEN, K.S. and THORSBY, E., HLA antigens and cervical carcinoma. Nature (Lond.), 356, 23 (1992).
16. HELLAND, Å, BØRRESEN, A.-L., KRISTENSEN, G. and RØNNINGEN, K.S., DQA1 and DQB1 genes in patients with squamous cell carcinoma of the cervix: relationship to human papillomavirus infection and prognosis. Cancer Epidemiol. Biomarkers Prevent., 3, 479-486 (1994).
17. HILDESHEIM, A., SCHIFFMAN, M.H., GRAVITT, P.E., GLASS, A.G., GREER, C.E., ZHANG, T., SCOTT, D.R., RUSH, B.R., LAWLER, P., SHERMAN, M.E., KURMAN, R.J. and MANOS, M.M., Persistence of type-specific human papillomavirus infection among cytological normal women. J. infect. Dis., 169, 235-240 (1994).
18. IARC WORKING GROUP ON THE EVALUATION OF THE CARCINOGENIC RISK ON HUMANS, Human papillomaviruses. IARC Monogr. Eval. Carcinog. Risks Hum., 64, 1-409 (1995).
19. KEATING, P.J., CROMME, F.V., DUGGAN-KEEN, M., SNIJDERS, P.J.F., WALBOOMERS, J.M.M., HUNTER, R.D., DYER, P.A. and STERN, P.L., Frequency of down-regulation of individual HLA-Aand -B alleles in cervical carcinomas in relation to TAP-1 expression. Brit. J. Cancer, 72, 405-411 (1995).
20. KELLY, A., POWIS, S.H., KERR, L.A., MOCKRIDGE, I., ELLIOTT, T., BASTIN, J., UCHANSKAZIEGLER, B., ZIEGLER, A., TROWSDALE, J. and TOWNSEND, A., Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex. Nature (Lond.), 355, 641-644 (1992).
21. KLITZ, W., ALDRICH, C.L., FILDES, N., HORNING, S.J. and BEGOVICH, A.B., Localization of predisposition to Hodgkin's disease in the HLA Class II region. Amer. J. hum. Genet., 54, 497-505 (1994).
22. KOCKUM, I., SANJEEVI, C.B., EASTMAN, S., LANDIN-OLSSON, M., DAHLQUIST, G. and LERNMARK, A., Population analysis of protection by HLA-DR and DQ genes from insulin-dependent diabetes mellitus in Swedish children with insulin-dependent diabetes and controls. Europ. J. Immunogenet., 22, 443-465 (1995).
23. MAIMAN, M., FRUCHTER, R.G., SERUR, E., REMY, J.C., TREUE, G.F. and BOYCE, J., Human immundeficiency virus infection and cervical neoplasia. Gynecol. Oncol., 38, 377-382 (1990).
24. MEHAL, W.Z., LO, Y.-M.D., HERRINGTON, C.S., EVANS, M.F., PAPADOPOULOS, M.C., ODUNSI, K., GANESAN, T.S., MCGEE, J.O'D., BELL, J.I. and FLEMING, K.A., Role of human papillomavirus in determining the HLA associated risk of cervical carcinogenesis. J. Clin. Pathol., 47, 1077-1081 (1994).
25. NAWA, A., NISHIYAMA, Y., KOBAYASHI, T., WAKAHARA, Y., OKAMOTO, T., KIKKAWA, F., SUGANUMA, N., GOTO, S., KUZUYA, K. and TOMODA, Y., Association of HLA-B1*03 with cervical cancer in Japanese women aged 35 years and younger. Cancer, 75, 518-521 (1995).
26. NUCHTERN, J.G., BIDDISON, W.E. and KLAUSNER, R.D., Class II MHC molecules can use the endogenous pathway of antigen presentation. Nature (Lond.), 343, 74-76 (1990).
27. ODUNSI, K., TERRY, G., HO, L., BELL, J., CUZICK, J. and GANESAN, T.S., Association between HLA DQB1*03 and cervical intra-epithelial neoplasia. Mol. Med., 1, 161-171 (1995).
28. ODUNSI, K., TERRY, G., HO, L., BELL, J., CUZICK, J. and GANESAN, T.S., Susceptibility to human papillomavirus-associated cervical infra-epithelial neoplasia is determined by specific HLA DR-DQ alleies. Int. J. Cancer, 67, 595-602 (1996).
29. OLSEN, A.O., DILLNER, J., GJØKN, K., SAUER, T., ØRSTAVIK, I. and MAGNUS, P., A population-based case-control study of human papillomavirus-type-16 seropositivity and incident high-grade dysplasia of the uterine cervix. Int. J. Cancer, 68, 415-419 (1996).
30. OLSEN, A.O., GJØEN, K., SAUER, T., ØRSTAVIK, I., NÆss, O., KIERULF, K., SPONLAND, G. and MAGNUS, P., Human papillomavirus and cervical intraepithelial neoplasia grade I-III: a population-based case-control study. Int. J. Cancer, 61, 312-315 (1995).
31. PANZA, N., DEL VECCHIO, L., MAIO, M., DE FELICE, M., LOMBARDI, G., MINOZZI, M. and ZAPPACOSTA, S., Strong association between an HLA-DR antigen and thyroid carcinoma. Tissue Antigens, 20, 155-158 (1982).
32. PETRY, K.U., SCHEFFEL, D., BODE, U., GABRYSIAK, T., KÖCHEL, H., KUPSCH, E., GLAUBITZ, M., NIESERT, S., KUHNLE, H. and SCHEDEL, I. Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions. Int J. Cancer, 57, 836-840 (1994).
33. RØNNINGEN, K.S., IWE, T., HALSTENSEN, T.S., SPURKLAND, A. and THORSBY, E., The amino acid position 57 of the HLA-DQB chain and susceptibility to develop insulin-dependent diabetes mellitus. Hum. Immunol., 26, 215-225 (1989).
34. RONMNGEN, K.S., SPURKLAND, A., MARKUSSEN, G., IWE, T., VARTDAL, F. and THORSBY, E., Distribution of class II alleies among Norwegian Caucasians. Hum. Immanol. 29, 276-281 (1990).
35. RØNNINGEN, K.S., UNDLIEN, D.E., PLOSKI, R., MAOUNI, N., KONRAD, R.J., JENSEN, E., HORNES, E., COLONNA, M., MONOS, D., STROMINGER, J.L. and THORSBY, E., Linkage disequilibrium between TAP2 variants and HLA class II alleies. No primary association between TAP2 variants and insulin-dependent diabetes mellitus. Europ. J. Immunol., 23, 1050-1056 (1993).
36. SANJEEVI, C.B., HJELMSTRØM, P., HALLMANS, G., WIKLUND, F., LENNER, P., ÅNGSTRØM, T., DILLNER, J. and LERNMARK, Å., Different HLA-DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papilomavirus type 16 seropositive and seronegative women. Int. J. Cancer, 68, 409-414 (1996).
37. SASTRE-GARAU, X., LOSTE, M.-N., VINCENT-SALOMON, A., FAVRE, M., MOURET, E., DE LA ROCHEFORDIERE, A., DURAND, J.-C, TARTOUR, E., LEPAGE, V. and CHARRON, D., Decreased frequency of HLA-DRB1*13 alleies in French women with HPV-positive carcinoma of the cervix. Int. J. Cancer (Pred. Oncol.), 69, 159-164 (1996).
38. SCHIFFMAN, M., BAUER, H., HOOVER, R., GLASS, A.G., CADELL, D.M., RUSH, B.B., SCOTT, D.R., SHERMAN, M.E., KURMAN, R.J., WACHOLDER, S., STANTON, S. and MANOS, M., Epidemiological evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. nat. Cancer Inst., 85, 958-964 (1993).
39. VANDENVELDE, C.X., DE FOOR, M. and VAN BEERS, D., HLA-DQB 1*03 and cervical intraepithelial neoplasia grades I-III. Lancet 341, 442-443 (1993).
40. WANK, R. and THOMSSEN, C., High risk for squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature (Lond.), 352, 723-725 (1991).
41. YASUNAGA, S., KIMURA, A., HAMAGUCHI, K., RONNINGEN, K.S. and SASAZUKI, T., Different contribution HLA-DR-DQ loci in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM). Tissue Antigens, 47, 37-48 (1996).
42. ZUR HAUSEN, H., Viruses in human cancers. Science, 254, 1167-1173 (1991).